Navigation Links
Jefferson radiation oncologists use real-time system to plant 'seeds' against cancer
Date:9/23/2007

(PHILADELPHIA) Radiation oncologists and urologists at the Kimmel Cancer Center at Jefferson and Thomas Jefferson University Hospital in Philadelphia have begun using a real-time system to implant radiation-emitting seeds in prostate cancer patients. While the system, which is made by Nucletron, a technology company based in The Netherlands, is only being used for imaging and planning purposes so far, it ultimately will help with the actual placement of the seeds. To date, Jefferson is the first medical center in the Delaware Valley to begin employing the new system.

The multidisciplinary team of urologists, surgeons, radiation oncologists, radiation physicists and others involved in using the device are hoping that the new federal Food and Drug Administration-approved technology will make an already good system even better, adding scientific precision to a treatment that currently relies mainly on physician experience and skill.

The device is a step above the traditional technique because it makes use of a more sophisticated approach that allows for a coordinated, real-time imaging-based implantation of seeds, Richard Valicenti, M.D., associate professor of radiation oncology at Jefferson Medical College of Thomas Jefferson University, says about the Nucletron device.

Patients have two options for treatment for localized, low-risk prostate cancer confined to the prostate: surgery or radiation therapy. In brachytherapy, tiny pellets seeds about the size of a grain of rice blanket the prostate, giving off radiation that travels only a few millimeters to kill nearby cancer cells. The seeds are carefully placed inside the cancerous tissue and positioned to efficiently attack the cancer. Brachytherapy has been proven to be very effective and safe, providing a good alternative to surgical removal of the prostate, while reducing the risk of certain long-term side effects, such as impotence. The seed radioactivity decays with time, while the seeds stay within the treatment area.

This new approach is automated, so what normally takes us many steps to do we can do very quickly, he says, noting that brachytherapy is highly operator-dependent. For example, putting in the rectal ultrasound probe has to be done slowly by hand. Now, the device does it and takes measurements of the size and location automatically of the target gland. It collects the imaging information the dimensions of the patients prostate and downloads this into a computer system, where it is rapidly processed.

The doctors, radiation physicists and other specialists then specify the parameters of treating the cancer, such as how much dose to give the prostate, how much extra dose to give to the area of the tumor and the positions in which to give the radiation, all in less time than previously possible with standard techniques, Dr. Valicenti says.

Up until recently, we would produce a plan in the outpatient setting that we hoped to recapitulate in the operating room, explains Adam Dicker, M.D. Ph.D., professor of radiation oncology at Jefferson Medical College. But there was always the concern that what we saw initially might not match the situation later. Planning, he explains, can be affected by the patients position and the location and condition of his prostate.

Because the device enables real-time planning in the operating room, he says, If an area is under-dosed, you can find out right away and make corrections. The system provides a multidimensional view of the prostate and the ability to process and accumulate more precise information, constantly updating and readjusting the treatment plan.


'/>"/>

Contact: Steve Benowitz
steven.benowitz@jefferson.edu
215-955-5291
Thomas Jefferson University
Source:Eurekalert

Related medicine news :

1. Jefferson Physicians Report on Potentially Fatal Complication of Heart Attack
2. Jefferson Researchers Want to Learn If Heart Defect at Heart of Some Migraines
3. Antioxidants protect health tissue in people undergoing radiation therapy.
4. Radiation for Bone Pain
5. Radiation for Bone Pain
6. Gene enchances radiation therapy - A novel approach to fight cancer
7. Radiation before surgery cuts cancer recurrence
8. UV Radiation induces Melanoma
9. Low-radiation treatment for brain tumours
10. Lack of solar radiation causes cancer
11. Microwave radiation has no hazards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... April 24, 2017 , ... Ridgecrest Herbals makes it a point to lead ... reduce waste, and support renewable energy. They believe this is a crucial part of ... solutions for health issues, and maintain that destroying the environment in the pursuit of ...
(Date:4/24/2017)... Antonio, TX (PRWEB) , ... April 24, 2017 , ... ... by the glitterati, those unreal icons inhabiting the rarified air of pop and film ... the paparazzi and anyone snapping pictures: the smile. Grins now run the gamut from ...
(Date:4/24/2017)... ... April 24, 2017 , ... Sean Fay is the undisputed ... Sonicare Toothbrush, Juiceman Juicer, and the George Foreman Grill (which sold more than 100 ... in the last 25 years. , Now, due to changes in the broadcast media ...
(Date:4/24/2017)... ... April 24, 2017 , ... ALP Nutrition®, ... supplements, announced its popular products are now available for purchase on StackedNutrition.com, a ... the use of premium natural ingredients in making all of its products. These ...
(Date:4/24/2017)... (PRWEB) , ... April 24, 2017 , ... ... advisor within the telehealth industry, announces the company’s VideoMedicine mobile platform has launched ... providers. Available 24 hours a day, Quick Care provides patients with the option ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... Ind. , April 20, 2017  Zimmer Biomet ... in musculoskeletal healthcare, today announced that it will be ... Care Conference at the InterContinental Hotel in ... Zimmer Biomet will present at 11:20 a.m. Eastern Time. ... be accessed via Zimmer Biomet,s Investor Relations website at ...
(Date:4/20/2017)... Research and Markets has announced the addition of the ... Market and Increasing Usage of Complex Biologics during the Forecast Period" ... ... 20 Billion in 2015 to around USD 26 Billion by 2020. ... by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics ...
(Date:4/20/2017)... , April 20, 2017  AbbVie (NYSE: ABBV), ... percent (n=145/146) of chronic hepatitis C virus (HCV) ... or 6 and compensated cirrhosis (Child-Pugh A) achieved ... 12 ) with its investigational, pan-genotypic regimen of ... were seen following 12 weeks of G/P treatment ...
Breaking Medicine Technology: